APH Options Market Flashes Extreme Fear After 49% Crash
Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Why this matters: Amphenol shares have fallen nearly 50% in one month. The options market just printed its most bearish reading in 52 weeks. Short sellers are piling in.
The Options Signal Is the Standout
The put-call ratio hit 3.94 on September 3. That is the highest level in a full year. The 20-day average PCR was 0.96. The z-score is 4.36 — an extreme statistical outlier. Traders are buying puts at a rate nearly four times the volume of calls. The prior month's PCR readings sat in a tight band between 0.75 and 0.84. The September 3 print breaks that range by a factor of nearly five.
Shorts Double Overnight
Short interest jumped 89% in a single day. As of September 3, 28 million shares are short — 2.29% of the free float. A month ago, the figure was closer to 16.8 million. The cost to borrow doubled over the week to 0.48%. That remains historically low for this name. Availability is effectively uncapped — over 776 million shares remain available to borrow. There is no borrow squeeze here. New shorts face no friction entering positions.
A Stock in Freefall, Analysts Still Bullish
The price close on September 3 was $82.07. One month ago, the stock was trading near $163. Analysts raised targets as recently as July 30. UBS took its price target to $197. BNP Paribas went to $215. Citigroup lifted to $210. The consensus mean target sits at $192 — more than double the current price. That gap is extraordinary. Either analysts have not revised post-crash, or the market is pricing in something structurally damaging that consensus has not yet absorbed.
The next earnings date is October 28. That event will be pivotal.
Insiders Were Selling Before the Drop
Insider data through August 6 shows net selling of $180 million over 90 days. The CFO, Craig Lampo, exercised and sold 193,200 shares on August 4 at roughly $167. The EVP of Human Resources sold 120,000 shares on August 5 at $174. These were exercise-and-sell transactions — not discretionary open-market sales — but the timing, just weeks before a 50% collapse, is notable context.
Data Summary
- Price: $82.07 (–49% over one month, –49% over one week)
- Put-call ratio: 3.94 (52-week high; z-score 4.36 vs 20-day mean of 0.96)
- SI % of free float: 2.29% (up 89% in one day, up 68% over one month)
- Shares short: ~28 million
- Cost to borrow: 0.48% (doubled week-on-week, historically low)
- Availability: Effectively unlimited — over 776 million shares available
- Analyst mean price target: $192.12 (as of August 20)
- Insider net selling (90d): –$180 million
- Next earnings: October 28, 2026
Stocks in this article
See the live data behind this article on ORTEX.
Open APH on ORTEX →How this article was generated
- Generated
- 4 Sept 2026, 11:19
- Data as of
- 4 Sept 2026, 11:15
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.